Industry News
Understanding How Oncogenes Affect The Body Clock May Help Create Better Cancer Treatments
Apr 11, 2013
The Myc oncogene can disrupt the 24-hour internal rhythm in cancer cells... Read More
A Promising Drug Can Help Prevent Head And Neck Cancers
Apr 11, 2013
Head and neck cancers typically begin in squamous cells that line moist surfaces inside the mouth, nose and throat. Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most common type of cancer in the United States, and it is sometimes preceded by the appearance of changes inside the oral cavity called precancerous lesions... Read More
Inhibiting Growth Of Triple-Negative Breast Cancer With Omega-3 Fatty Acids
Apr 11, 2013
Researchers from Fox Chase Cancer Center have found that omega-3 fatty acids and their metabolite products slow or stop the proliferation, or growth in the number of cells, of triple-negative breast cancer cells more effectively than cells from luminal types of the disease... Read More
During Pregnancy, Excess Estrogen Can Silence BRCA1 In Daughters, Increasing Breast Cancer Risk
Apr 11, 2013
Excess estrogen levels during pregnancy can disable, in their daughters, a powerful breast cancer tumor suppressor gene, say researchers at Georgetown Lombardi Comprehensive Cancer Center. They found the DNA repair gene BRCA1 to be silenced in one year-old girls exposed to a high hormonal fetal environment... Read More
Heterogeneity Quantified In Early Stage Breast-Cancer, Which Ultimately Could Help Doctors To Eradicate It Before More Invasive Cancers Develop
Apr 11, 2013
A variety of mutations may give rise to breast cancer, but scientists generally assume that it starts off with just a few. That's because later-stage breast cancers tend to have more mutations - they are more heterogeneous - than early stage cancers... Read More
Critical Metabolic Alterations Identified In Triple-Negative Breast Cancer Cells
Apr 11, 2013
Researchers at Fox Chase Cancer Center have identified a host of small molecules critical to metabolism in cells of triple-negative breast cancer - one of the least understood groups of breast cancer. These molecules, called metabolites, include key players in energy regulation and lipid synthesis... Read More
Study Finds Bird Virus Promising For Prostate Cancer Treatment
Apr 11, 2013
A study at the Virginia-Maryland Regional College of Veterinary Medicine has identified a chicken-killing virus as a promising treatment for prostate cancer in humans. Researchers have discovered that a genetically engineered Newcastle disease virus, which harms chickens but not humans, kills prostate cancer cells of all kinds, including hormone-resistant cancer cells. The work of Dr... Read More
Endometriosis Treatments Lower Ovarian Cancer Risk
Apr 11, 2013
A novel study shows women who undergo surgical treatment for endometriosis have a lower risk of developing ovarian cancer. According to results published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, hormonal treatments for endometriosis did not lower ovarian cancer risk... Read More
FDA Step Closer To Approving Breast Cancer Drug "Palbociclib"
Apr 11, 2013
The pharmaceutical giant Pfizer has just announced that their drug "Palbociclib", a selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has just received Breakthrough Therapy designation by the United States Food and Drug Administration (FDA) for breast cancer treatment. Breast cancer is the most common cancer among women worldwide... Read More
Fetal Exposure To Air Pollution Increases Risk Of Pediatric Cancers
Apr 10, 2013
Pregnant women exposed to air pollution put their children at an increased risk of three different types of cancer, according to new research presented at the AACR Annual Meeting 2013. In their study, researchers identified that prolonged exposure to traffic-related air pollution can increase a child's risk of acute lymphoblastic leukemia and two other rare childhood cancers... Read More
Previous Page Next Page